GCell Autologous Tissue Seperation Device

GCell is an advanced autologous tissue processing device based on a closed system workflow, designed to mechanically process different autologous tissue sources to obtain cellular cocktails rich in tissue derived cellular components.

GCell enables adipose tissue and post auricular (retroauricular) tissue to be processed as two distinct tissue sources, each according to its specific processing protocol.

SVF Processing:

Autologous adipose tissue harvested from the patient is subjected to controlled mechanical disaggregation and homogenization within the GCell system, resulting in an adipose tissue derived cellular cocktail known as Stromal Vascular Fraction (SVF).

Micrograft Processing:

A small amount of autologous tissue harvested from the hair bearing or non hair bearing area behind the ear is mechanically disaggregated according to a separate processing protocol to obtain a tissue derived cellular cocktail.

Both procedures are performed using a closed system, sterile, single use kit. GCell provides a controlled and standardized approach for processing different autologous tissue sources according to their intended clinical applications.